Noninvasive imaging biomarkers of chronic liver disease severity and prognosis
PURPOSE: To evaluate whether MRI-derived functional and morphologic biomarkers are associated with clinical severity and prognosis in chronic liver disease (CLD). MATERIALS AND METHODS: In this retrospective single-center study, 165 adults with chronic liver disease (CLD) who underwent gadoxetic acid-enhanced MRI were included. Functional Liver Imaging Score (FLIS) was assessed on 20-min hepatobiliary-phase images, and Liver Surface Nodularity (LSN) was measured on contrast-enhanced axial T1-weighted images using semi-automated software. Spearman correlation analysis was performed for associations with Model for End-Stage Liver Disease 3.0 (MELD 3.0), and Albumin-Bilirubin score (ALBI). Time-to-event analyses for liver transplantation or death within 4 years were performed using Kaplan-Meier analysis and Cox proportional hazards models. Receiver operating characteristic (ROC) analysis was used to evaluate the performance of FLIS for predicting 1-year transplant-free survival (TFS). RESULTS: FLIS showed moderate inverse correlations with MELD 3.0 (ρ = - 0.532, p < 0.001) and ALBI score (ρ = - 0.541, p < 0.001). LSN showed weak positive correlations with MELD 3.0 (ρ = 0.154, p = 0.049) and ALBI score (ρ = 0.184, p = 0.018). In univariable Cox analysis, older age, lower FLIS, higher MELD 3.0, higher ALBI score, and LSN cutoff ≥ 3 were associated with a higher risk of liver transplantation/death. In multivariable analysis, age (hazard ratio (HR), 1.05; p < 0.001), MELD 3.0 (HR, 1.08; p = 0.003) and FLIS group (0-3 vs 4-6 points; HR, 2.39; p = 0.007) remained independently associated with liver transplantation or death. For 1-year TFS, FLIS with an optimal cutoff of ≤ 3 yielded an area under the curve (AUC) of 0.71 (95% confidence interval (CI), 0.61-0.82). CONCLUSION: Our findings suggest that MRI-derived functional and morphologic biomarkers, particularly FLIS, may provide noninvasive imaging markers of disease severity and prognosis in patients with CLD. Prospective studies with long-term clinical outcomes are needed to define their role in risk stratification and transplant decision-making.
Authors
- Daniela P. Ladner (ORCID: https://orcid.org/0000-0001-5526-8272)
- Görkem Durak (ORCID: https://orcid.org/0000-0002-1608-1955)
- Şükrü Mehmet Ertürk (ORCID: https://orcid.org/0000-0003-4086-675X)
- Naci Şenkal (ORCID: https://orcid.org/0000-0001-7072-8724)
- Amir Ali Borhani (ORCID: https://orcid.org/0000-0001-8963-2984)
- Oyku Ikizgul (ORCID: https://orcid.org/0009-0007-0534-1938)
- Maryam Haghshomar (ORCID: https://orcid.org/0000-0002-1854-4490)
- Andrea Bejar (ORCID: https://orcid.org/0000-0003-2089-5983)
- Yavuz Bahadır Taktak (ORCID: https://orcid.org/0009-0000-2558-416X)
- Alpay Medetalibeyoğlu (ORCID: https://orcid.org/0000-0002-3024-4036)
- Burak Gültekin
- Halil Ertugrul Aktas (ORCID: https://orcid.org/0009-0009-9491-8122)
- Gulbiz Dagoglu Kartal
- Kerem Arısın (ORCID: https://orcid.org/0009-0004-4613-6445)
- Ece Busra Elustu
- Muhammed Enes Tasci
- Derin Sanal
- Ayse Ece Taymez
- Irem Sena Bayrak (ORCID: https://orcid.org/0009-0001-5834-6165)
- Can Deniz Yokus
- İbrahim Halil Akkış (ORCID: https://orcid.org/0009-0005-8441-1345)
- Esin Ozkan
- Elif Keles
- Sabahattin Kaymakoglu
- Ulas Bagci
Institutions
- Northwestern University (US)
- Acıbadem Kadıköy Hospital (TR)
- Istanbul University (TR)
- Marmara University (TR)
Publication Details
- Journal
- Abdominal Radiology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1007/s00261-026-05866-7
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Cancer Institute